Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
An Open-label, Multi-Centre, Randomized, Parallel-group Study, Investigating the Efficacy and Safety of Degarelix One Month Dosing Regimens; 160 mg (40 mg/ml) and 80 mg (20mg/ml), in Comparison to LUPRON DEPOT® 7.5 mg in Patients with Prostate Cancer Requiring Androgen Ablation Therapy https://kusajili.com:443/Trial/nEhPgoXhskuZec0UqgyPIw%24an-open-label-multi-centre-randomized-parallel-group-study-investigating-the-efficacy-and-safety-of-degarelix-one-month-dosing-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message